Provided by Tiger Trade Technology Pte. Ltd.

Qiagen NV

34.58
+0.97002.89%
Post-market: 34.700.1200+0.35%19:58 EDT
Volume:4.41M
Turnover:150.82M
Market Cap:7.12B
PE:16.93
High:34.60
Open:33.56
Low:33.56
Close:33.61
52wk High:57.82
52wk Low:33.17
Shares:206.00M
Float Shares:204.03M
Volume Ratio:1.30
T/O Rate:2.16%
Dividend:0.26
Dividend Rate:0.75%
EPS(TTM):2.04
EPS(LYR):2.04
ROE:11.57%
ROA:5.77%
PB:1.89
PE(LYR):16.93

Loading ...

Earning Preview: Qiagen NV this quarter’s revenue is expected to increase by 6.58%, and institutional views are bullish

Earnings Agent
·
Apr 29

Qiagen (QGEN) Gets a Buy from DZ BANK AG

TIPRANKS
·
Yesterday

Baird Upgrades QIAGEN to Outperform From Neutral, Cuts Price Target to $43 From $53

MT Newswires Live
·
Apr 29

Qiagen Raised to Outperform From Neutral by Baird

Dow Jones
·
Apr 29

QIAGEN Down Over 10%, on Track for Lowest Close Since November 2019 -- Data Talk

Dow Jones
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Eli Lilly & Co (LLY) and Janux Therapeutics Inc (JANX)

TIPRANKS
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Qiagen (QGEN)

TIPRANKS
·
Apr 28

Qiagen cuts FY26 EPS view to ‘at least’ $2.43 from ‘at least’ $2.50

TIPRANKS
·
Apr 28

Qiagen down 5% at $36.11 after Q1 pre-announcement, FY26 guidance cut

TIPRANKS
·
Apr 28

Press Release: QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook

Dow Jones
·
Apr 28

Unusually active option classes on open April 27th

TIPRANKS
·
Apr 27

How Investors May Respond To Qiagen (QGEN) Entering Rapid Bloodstream Infection Testing With New Panel

Simply Wall St.
·
Apr 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tandem Diabetes Care (TNDM) and Qiagen (QGEN)

TIPRANKS
·
Apr 15

Qiagen expands into bloodstream infection syndromic testing

TIPRANKS
·
Apr 15

Is Qiagen (QGEN) Offering Value After Mixed Share Price Performance?

Simply Wall St.
·
Apr 14

Qiagen price target raised to EUR 44 from EUR 43 at Morgan Stanley

TIPRANKS
·
Apr 14

Qiagen Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
Apr 14

Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48

MT Newswires Live
·
Apr 14

How Investors May Respond To Qiagen (QGEN) Upgrade After Reaffirmed 5% Outlook And New Product Plans

Simply Wall St.
·
Apr 07

Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection

Simply Wall St.
·
Mar 28